Centric Wealth Management Abbott Laboratories Transaction History

Centric Wealth Management

$415 Million
Q3 2025

A detailed history of Centric Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Centric Wealth Management holds 3,038 shares of ABT stock, worth $395,031. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,038

Previous 2,983 1.84%

Holding current value

$395,031

Previous $405,000 0.25%

% of portfolio

0.1%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$120.51 - $136.62 $6,628 - $7,514	55 Added 1.84%	3,038 $406,000
Q2 2025 Aug 12, 2025	SELL	$123.95 - $138.08 $33,962 - $37,833	-274 Reduced 8.41%	2,983 $405,000
Q1 2025 May 15, 2025	SELL	$111.1 - $140.22 $2,666 - $3,365	-24 Reduced 0.73%	3,257 $432,000
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $200 - $236	2 Added 0.06%	3,281 $374,000
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $81,289 - $90,739	807 Added 32.65%	3,279 $340,000

Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $3,176 - $3,507	-29 Reduced 1.16%	2,472 $280,000
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $176,231 - $215,721	-1,954 Reduced 43.86%	2,501 $275,000
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $2,197 - $2,636	-23 Reduced 0.51%	4,455 $431,000
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $94,128 - $104,878	934 Added 26.35%	4,478 $488,000
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $39,422 - $46,402	-407 Reduced 10.3%	3,544 $358,000
Q4 2022 Jan 04, 2023	SELL	$95.06 - $111.52 $27,947 - $32,786	-294 Reduced 6.93%	3,951 $0
Q3 2022 Oct 05, 2022	BUY	$96.76 - $112.03 $28,640 - $33,160	296 Added 7.5%	4,245 $411,000
Q2 2022 Jul 06, 2022	BUY	$102.07 - $123.37 $11,227 - $13,570	110 Added 2.87%	3,949 $429,000
Q1 2022 Apr 05, 2022	BUY	$114.02 - $139.04 $66,245 - $80,782	581 Added 17.83%	3,839 $454,000
Q4 2021 Jan 27, 2022	SELL	$115.53 - $141.46 $28,882 - $35,365	-250 Reduced 7.13%	3,258 $458,000
Q3 2021 Oct 06, 2021	BUY	$116.66 - $129.06 $9,332 - $10,324	80 Added 2.33%	3,508 $414,000
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $199,943 - $235,361	-1,890 Reduced 35.54%	3,428 $397,000
Q1 2021 Apr 14, 2021	SELL	$108.84 - $128.23 $25,142 - $29,621	-231 Reduced 4.16%	5,318 $637,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $582,645 - $634,916	5,549 New	5,549 $608,000
Q3 2020 Oct 05, 2020	SELL	$91.64 - $111.29 $449,402 - $545,766	-4,904 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$76.57 - $98.0 $375,499 - $480,592	4,904 New	4,904 $448,000
Q1 2020 Apr 08, 2020	SELL	$62.82 - $91.86 $247,824 - $362,387	-3,945 Closed	0 $0
Q4 2019 Jan 06, 2020	BUY	$78.51 - $87.4 $309,721 - $344,793	3,945 New	3,945 $343,000

Others Institutions Holding ABT

# of Institutions

3,646

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Centric Wealth Management with notifications on news.

Account

Centric Wealth Management Abbott Laboratories Transaction History